BioLife Solutions, Inc. (BLFS)

BioLife Solutions Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	22.01	35.41	19.44	69.86	90.4	6.45
Short-Term Investments	12.12	16.29	43.26	-	-	-
Cash & Short-Term Investments	34.13	51.7	62.7	69.86	90.4	6.45
Cash Growth	-26.21%	-17.55%	-10.25%	-22.72%	1302.03%	-78.97%
Receivables	18.06	18.66	33.94	23.22	8.01	5.35
Inventory	32.5	43.46	34.9	28.35	11.6	10.97
Prepaid Expenses	3.48	6.77	6.88	4.66	4.65	1.35
Restricted Cash	0.03	0.03	0.03	0.01	0.05	-
Total Current Assets	88.2	120.6	138.45	126.09	114.71	24.11
Property, Plant & Equipment	38.79	40.33	48.27	46.61	24.52	10.53
Long-Term Investments	3.68	5.62	6.4	4.37	5.87	2.5
Goodwill	224.74	224.74	224.74	224.74	58.45	33.64
Other Intangible Assets	19.33	21.15	32.09	152.15	31.05	21.98
Other Long-Term Assets	0.24	0.27	0.28	0.33	0.23	0.05
Total Assets	374.98	412.71	450.23	554.29	234.83	92.82
Accounts Payable	4.21	6.94	15.37	14.95	3.67	3.12
Accrued Expenses	12.04	16.15	12.36	8.6	3.37	1.86
Short-Term Debt	-	-	-	-	-	0.01
Current Portion of Long-Term Debt	10.61	6.83	1.81	0.86	0.61	-
Current Portion of Leases	2.82	3.17	3.02	2.91	1.12	0.8
Current Income Taxes Payable	0.31	0.56	0.98	0.03	0.11	-
Current Unearned Revenue	0.64	0.66	0.55	0.81	0.93	0.32
Other Current Liabilities	0.18	7.86	10.5	14.55	5.76	1.55
Total Current Liabilities	30.82	42.18	44.58	42.7	15.57	7.67
Long-Term Debt	10.45	18.31	23.79	6.35	0.66	-
Long-Term Leases	12.07	14.37	15.09	16.76	8.77	0.55
Long-Term Deferred Tax Liabilities	0.19	0.19	0.25	5.49	-	-
Other Long-Term Liabilities	-	-	2.33	4.94	4.59	41.14
Total Liabilities	53.53	75.05	86.04	76.24	29.58	49.36
Common Stock	0.05	0.05	0.04	0.04	0.03	0.02
Additional Paid-In Capital	667.81	651.31	611.74	585.4	302.6	143.49
Retained Earnings	-345.86	-313.34	-246.92	-107.11	-97.39	-100.05
Comprehensive Income & Other	-0.56	-0.35	-0.68	-0.28	-	-
Total Common Equity	321.44	337.66	364.19	478.05	205.25	43.45
Shareholders' Equity	321.44	337.66	364.19	478.05	205.25	43.45
Total Liabilities & Equity	374.98	412.71	450.23	554.29	234.83	92.82
Total Debt	35.96	42.69	43.71	26.88	11.15	1.37
Net Cash (Debt)	-1.82	9	18.99	42.98	79.25	5.08
Net Cash Growth	-	-52.58%	-55.82%	-45.77%	1459.73%	-83.43%
Net Cash Per Share	-0.04	0.21	0.45	1.12	2.90	0.26
Filing Date Shares Outstanding	46.14	45.3	43.21	42.09	33.4	24
Total Common Shares Outstanding	46.1	45.17	42.83	41.82	33.04	20.83
Working Capital	57.38	78.43	93.87	83.39	99.14	16.44
Book Value Per Share	6.97	7.48	8.50	11.43	6.21	2.09
Tangible Book Value	77.38	91.77	107.36	101.16	115.75	-12.17
Tangible Book Value Per Share	1.68	2.03	2.51	2.42	3.50	-0.58
Machinery	26.78	30.58	30.14	24.18	14.15	9.05
Construction In Progress	7.91	6.6	6.75	4.42	2.54	1.02
Leasehold Improvements	5.29	5.91	5.25	3.84	2.39	2.11

Source: S&P Capital IQ. Standard template. Financial Sources.